![](https://bigul.co/stock-screener/assetData/img/bar-shape.png)
![](https://bigul.co/stock-screener/assetData/img/pointer.png)
Bullish Moving Averages
12
Bearish Moving Averages
4
Products
Investments
Back Stocks profile
Today’s low
104.20Today’s High
108.0052W low
80.0052W High
186.40Open Price
105.20Prev. Close
95.5500Volume
608565.00Value
65104283.70Market Cap
1791.90
Price to Earnings
-19.30
Price to Book Value
2.10
Dividend Yield
0.00
PE to Growth
0.10
Op Revenue TTM
1613.06
Net Profit TTM
-92.75
Cash From Operating Activity
138.98
Return on Equity %
-10.72
EMA & SMA
Bullish Moving Averages
12
Bearish Moving Averages
4
DELIVERY AND VOLUME
05 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
108.55
Second Resistance
110.12
Third Resistance
112.29
First Support
104.81
Second Support
102.64
Third Support
101.07
Relative Strength Index
56.3
Money Flow Index
36.54
MACD
1.1
MACD Signal
1.37
Average True Range
4.02
Average Directional Index
18.11
Rate of Change (21)
17.5
Rate of Change (125)
-19.68
Commodity Channel Index
2.5
Williams %R
-59.3
BETA
1 Month
0.93
3 Month
0.78
1 Year
0.63
3 Year
0.13
PRICE CHANGE ANALYSIS
1 Week
Low
High
102.6
108.41
1 Month
Low
High
91.85
113.5
3 Months
Low
High
79.95
114.05
6 Months
Low
High
79.95
138.95
1 Year
Low
High
79.95
186.35
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 225.88 | 187.73 | 211.85 | 167.12 | 219.40 | 183.71 | 255.25 | 168.17 | 208.95 | 207.47 | 139.17 | |
Operating Expenses Qtr | 245.98 | 179.72 | 184.86 | 136.02 | 183.87 | 145.17 | 200.94 | 140.16 | 170.11 | 177.10 | 135.22 | |
Operating Profit Qtr | -25.65 | 5.89 | 21.35 | 25.09 | 34.29 | 27.52 | 42.21 | 15.28 | 31.28 | 23.13 | 2.95 | |
EBIDT Qtr Cr | -22.02 | 8.01 | 26.99 | 31.11 | 35.53 | 38.53 | 54.31 | 28.02 | 38.84 | 30.38 | 3.96 | |
Depreciation Qtr | 12.78 | 12.40 | 12.41 | 11.80 | 10.72 | 7.54 | 7.29 | 7.28 | 6.90 | 6.72 | 6.62 | |
Net Profit Qtr | -44.07 | -11.64 | -1.46 | 5.78 | 7.80 | 15.79 | 18.68 | 5.27 | 15.75 | 12.38 | -6.99 | |
Basic EPS Qtr | -2.65 | -0.70 | -0.09 | 0.36 | 0.51 | 1.01 | 1.19 | 0.34 | 1.21 | 0.97 | -0.55 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 792.14 | 818.27 | 704.21 | 605.52 | 603.84 | |
Operating Expenses Annual Cr | 746.13 | 661.88 | 608.03 | 538.18 | 520.07 | |
Operating Profit Annual | 27.13 | 127.56 | 77.48 | 61.87 | 59.71 | |
Operating Profit Margin Annual % | 3.42 | 15.59 | 11.00 | 10.22 | 9.89 | |
Total Expenses Annual Cr | 849.85 | 751.64 | 668.14 | 590.00 | 559.42 | |
EBIDT Annual Cr | 46.01 | 156.39 | 96.19 | 67.34 | 83.78 | |
EBIDT Annual margin % | 5.81 | 19.11 | 13.66 | 11.12 | 13.87 | |
Depreciation | 49.39 | 32.82 | 26.68 | 19.28 | 11.28 | |
PAT Before ExtraOrdinary Items Annual Cr | -51.39 | 47.55 | 25.87 | 8.28 | 30.72 | |
Net Profit Annual | -51.39 | 47.55 | 25.87 | 8.28 | 30.72 | |
Basic EPS Annual | -3.09 | 3.18 | 1.98 | 0.67 | 2.53 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 715.71 | 638.83 | 589.03 | 461.33 | 373.49 | |
Minority Interest Liability Annual Cr | - | - | - | - | - | |
Total Non Current Liabilities Annual Cr | 248.82 | 322.10 | 283.41 | 176.34 | 123.96 | |
Total Current Liabilities Annual Cr | 607.46 | 629.57 | 470.19 | 425.74 | 390.58 | |
Total Capital Plus Liabilities Annual Cr | 1571.99 | 1593.81 | 1345.94 | 1066.71 | 891.35 | |
Fixed Assets Annual | 607.96 | 611.40 | 511.14 | 312.17 | 293.84 | |
Total Non Current Assets Annual | 711.49 | 718.09 | 625.39 | 408.74 | 380.18 | |
Total Current Assets Annual | 860.50 | 875.72 | 720.55 | 657.97 | 511.17 | |
Total Assets Annual | 1571.99 | 1593.81 | 1345.94 | 1066.71 | 891.35 | |
Contingent Liabilities plus Commitments Annual Cr | - | 135.06 | 138.98 | 125.63 | 257.70 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 82.10 | 18.52 | 46.80 | 26.02 | 73.90 | |
Cash from Investing Activity Annual | -51.72 | -114.73 | -172.33 | -88.00 | -66.03 | |
Cash from Financing Annual Activity | -34.05 | 78.39 | 128.92 | 80.05 | -26.06 | |
Net Cash Flow Annual | - | -17.82 | 3.39 | 18.08 | -18.19 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 42.74 | 40.67 | 37.52 | 36.18 | 30.80 | |
ROE Annual % | -7.18 | 7.44 | 4.39 | 1.79 | 8.22 | |
ROCE Annual % | -0.35 | 12.81 | 7.93 | 7.49 | 14.47 | |
Total Debt to Total Equity Annual | 0.69 | 0.95 | 0.76 | 0.81 | 0.89 | |
EBDIT Annual Margin % | 5.95 | 19.81 | 14.03 | 11.22 | 14.44 |
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 407.46 | 387.55 | 407.64 | 425.97 | 428.70 | 397.60 | 486.12 | 384.80 | 410.54 | 386.40 | 311.84 | |
Operating Expenses Qtr | 414.95 | 362.56 | 380.75 | 380.89 | 382.89 | 338.08 | 428.04 | 337.15 | 364.90 | 325.65 | 288.51 | |
Operating Profit Qtr | -13.25 | 23.32 | 25.13 | 38.71 | 43.82 | 49.76 | 55.21 | 46.62 | 24.33 | 55.17 | 22.71 | |
EBIDT Qtr Cr | -57.29 | 24.99 | 26.89 | 45.08 | 36.14 | 59.52 | 58.09 | 47.65 | 45.65 | 60.75 | 23.33 | |
Depreciation Qtr | 20.05 | 20.58 | 19.20 | 18.78 | 17.93 | 16.18 | 14.02 | 14.37 | 15.94 | 13.24 | 13.37 | |
Net Profit Qtr | -77.14 | -11.79 | -19.38 | 15.55 | 9.16 | 24.04 | 13.02 | 5.89 | 15.13 | 28.72 | -5.53 | |
Basic EPS Qtr | -4.64 | -0.71 | -1.17 | 0.96 | 0.59 | 1.53 | 0.83 | 0.37 | 1.16 | 2.25 | -0.43 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 1628.62 | 1687.36 | 1445.12 | 1192.09 | 1052.58 | |
Operating Expenses Annual Cr | 1539.15 | 1476.29 | 1259.28 | 1005.17 | 918.44 | |
Operating Profit Annual | 73.92 | 205.27 | 152.81 | 181.93 | 130.70 | |
Operating Profit Margin Annual % | 4.54 | 12.17 | 10.57 | 15.26 | 12.42 | |
Total Expenses Annual Cr | 1678.06 | 1597.31 | 1351.01 | 1086.99 | 994.38 | |
EBIDT Annual Cr | 89.47 | 211.07 | 185.84 | 186.92 | 134.13 | |
EBIDT Annual margin % | 5.49 | 12.51 | 12.86 | 15.68 | 12.74 | |
Depreciation | 78.61 | 62.51 | 55.96 | 44.29 | 32.80 | |
PAT Before ExtraOrdinary Items Annual Cr | -104.88 | 39.81 | 60.51 | 65.36 | 29.83 | |
Net Profit Annual | -92.75 | 52.11 | 60.68 | 50.96 | 30.32 | |
Basic EPS Annual | -5.58 | 3.41 | 4.56 | 3.68 | 2.50 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 864.75 | 816.06 | 744.62 | 640.09 | 399.83 | |
Minority Interest Liability Annual Cr | -7.80 | 4.71 | 17.12 | 69.75 | 56.97 | |
Total Non Current Liabilities Annual Cr | 362.50 | 443.03 | 439.78 | 290.82 | 226.13 | |
Total Current Liabilities Annual Cr | 732.27 | 792.99 | 595.25 | 477.63 | 547.83 | |
Total Capital Plus Liabilities Annual Cr | 1951.72 | 2060.10 | 1800.08 | 1481.60 | 1234.06 | |
Fixed Assets Annual | 815.14 | 847.84 | 763.45 | 562.91 | 440.13 | |
Total Non Current Assets Annual | 951.06 | 972.28 | 906.54 | 686.91 | 559.11 | |
Total Current Assets Annual | 1000.67 | 1087.82 | 893.54 | 794.69 | 674.96 | |
Total Assets Annual | 1951.72 | 2060.10 | 1800.08 | 1481.60 | 1234.06 | |
Contingent Liabilities plus Commitments Annual Cr | - | 44.98 | 53.61 | 125.63 | 10.55 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 138.98 | 50.90 | 145.45 | 117.38 | 86.02 | |
Cash from Investing Activity Annual | -66.50 | -124.63 | -249.13 | -132.86 | -90.12 | |
Cash from Financing Annual Activity | -85.97 | 59.66 | 135.97 | 38.63 | 3.25 | |
Net Cash Flow Annual | - | -14.07 | 32.29 | 23.15 | -0.85 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 51.17 | 48.18 | 43.26 | 47.81 | 37.67 | |
ROE Annual % | -10.72 | 6.92 | 9.16 | 9.43 | 7.58 | |
ROCE Annual % | 0.89 | 11.72 | 10.77 | 14.20 | 14.76 | |
Total Debt to Total Equity Annual | 0.76 | 1.04 | 0.94 | 1.00 | 1.22 | |
EBDIT Annual Margin % | 5.54 | 12.55 | 13.16 | 15.74 | 12.78 |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
Icici Prudential Smallcap Fund | 2.69 | 74203185 | - | - |
Urjita J Master | 1.02 | 74203201 | - | - |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
Ashish Subhash Dandekar | 11.73 | 74203166 | 50.89 | 0 |
Subhash Digambar Dandekar | 0.61 | 74203167 | 0 | 0 |
Infinity Holdings | 6.37 | 74203180 | 0 | 93.78 |
Infinity Direct Holdings | 12.35 | 74203176 | 0 | 93.53 |
Anfima Nv | 6.62 | 74203177 | 0 | 0 |
Infinity Direct Holdings Sidecar I | 3.31 | 74203178 | 0 | 0 |
Camart Finance Limited | 3.18 | 74203171 | 0 | 0 |
Vibha Agencies Pvt Ltd | 1.56 | 74203172 | 0 | 0 |
Cafco Consultants Limited | 0.89 | 74203173 | 0 | 0 |
Anagha Subhash Dandekar | 1.37 | 74203182 | 0 | 0 |
Name | Holding Percent | Holding Id |
---|---|---|
Icici Prudential Smallcap Fund | 2.69 | 74203185 |
Name | Holding Percent | Holding Id |
---|---|---|
Urjita J Master | 1.02 | 74203201 |
Jagdish N Master | 1.02 | 74203200 |
HUF | 1.52 | 74203192 |
Nirmal Vinod Momaya | 2.15 | 74203206 |
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
---|---|---|---|---|
Jul 28, 2016 | 0.45 | FINAL | - | Equity Share |
Jul 27, 2015 | 0.45 | FINAL | - | Equity Share |
Jul 24, 2014 | 0.7 | FINAL | - | Equity Share |
Aug 01, 2013 | 0.6 | FINAL | - | Equity Share |
Jul 23, 2012 | 0.5 | FINAL | - | Equity Share |
Jul 20, 2011 | 2 | FINAL | - | Equity Share |
Jun 22, 2010 | 2 | FINAL | - | Equity Share |
Aug 12, 2009 | 1.5 | FINAL | - | Equity Share |
Jul 30, 2008 | 1 | FINAL | - | Equity Share |
Ex-Date | Split Ratio | Record Date |
---|---|---|
Sep 04, 2014 | 2:1 | - |
Feb 15, 2012 | 10:2 | 2012-02-17 |
Ex-Date | Purpose | Notes |
---|---|---|
May 20, 2024 | Audited Results | - |
Feb 09, 2024 | Quarterly Results | - |
Nov 06, 2023 | Quarterly Results | - |
Aug 11, 2023 | Quarterly Results | - |
May 22, 2023 | Audited Results | - |
Feb 13, 2023 | Quarterly Results | - |
Nov 12, 2022 | Quarterly Results | - |
Aug 12, 2022 | Quarterly Results | - |
May 19, 2022 | Audited Results | - |
Feb 07, 2022 | Quarterly Results | - |
Nov 12, 2021 | Quarterly Results | - |
Aug 13, 2021 | Quarterly Results | - |
May 28, 2021 | Audited Results & Dividend | - |
Feb 08, 2021 | Quarterly Results | - |
Nov 12, 2020 | Quarterly Results | - |
Aug 10, 2020 | Quarterly Results | - |
Jun 25, 2020 | Preferential Issue of shares | inter alia, consider and if thought fit, to consider fund raising options for the Company, by way of debt instruments or issuance of securities. |
Jun 19, 2020 | Audited Results | - |
Feb 07, 2020 | Quarterly Results | - |
Nov 08, 2019 | Quarterly Results | - |
Aug 02, 2019 | Quarterly Results | - |
May 24, 2019 | Audited Results | - |
Feb 08, 2019 | Quarterly Results | - |
Nov 06, 2018 | Quarterly Results | - |
Aug 13, 2018 | Quarterly Results | - |
Jun 27, 2018 | Others | Fund Raising/Other business matters To consider Fund Raising and other business matters. |
May 24, 2018 | Audited Results | - |
Feb 14, 2018 | Quarterly Results | - |
Dec 29, 2017 | Others | To inter-alia approve the issue price for the Preferential Allotment. |
Nov 29, 2017 | Preferential Issue of shares | Inter alia, to consider and approve raising funds through preferential allotment. |
Nov 01, 2017 | Quarterly Results | - |
Aug 28, 2017 | Quarterly Results | - |
May 19, 2017 | Audited Results, Dividend & Others | - |
Feb 10, 2017 | Quarterly Results | - |
Nov 10, 2016 | Quarterly Results | - |
Jul 01, 2016 | Others | (a). To approve the closure of the QIP;(b). To approve the issue price including a discount, if any thereto as permitted under the SEBI ICDR Regulations for the Equity Shares to be allotted. |
May 23, 2016 | Audited Results & Dividend | Re-appointment of Mr. Dattatraya R. Puranik as Executive Director & CFO of the Company for a period of 3 years w.e.f. August 01, 2016. |
Feb 12, 2016 | Quarterly Results | - |
Nov 06, 2015 | Quarterly Results | - |
Sep 25, 2015 | Others | 1. Setting up a Subsidiary in USA in place of joint-venture earlier approved in the Board Meeting held on August 05, 2015. 2. To raise funds not exceeding Rs.150.00 Crores by way of QIP/GDR/ADR/FCCB. |
Aug 05, 2015 | Quarterly Results | Approved setting up a Joint-Venture in USA for undertaking manufacturing, trading and distribution of antioxidants, food ingredients, blends, formulations etc in US and Canadian markets. |
May 12, 2015 | Audited Results & Dividend | 1. Re-appointment of Mr. Ashish S. Dandekar as a Managing Director of the Company. 2. Acquisition of land admeasuring 64,407.91 square meters and setting up a manufacturing facility. |
Feb 06, 2015 | Quarterly Results | - |
Nov 13, 2014 | Quarterly Results | - |
May 29, 2014 | Audited Results & Dividend | - |
Feb 10, 2014 | Quarterly Results | - |
Nov 12, 2013 | Quarterly Results | - |
Aug 13, 2013 | Quarterly Results | - |
May 21, 2013 | Audited Results & Dividend | - |
Jan 29, 2013 | Quarterly Results | - |
Nov 01, 2012 | Quarterly Results | - |
Aug 01, 2012 | Quarterly Results | - |
May 24, 2012 | Audited Results & Dividend | - |
Feb 06, 2012 | Quarterly Results & Others | Inter alia, for Fixing of Record Date for Sub-Division of Equity Share from face value of Rs. 10/- each to face value of Re. 2/- each. |
Nov 10, 2011 | Quarterly Results & Stock split | To consider sub-division of the Co's Equity Shares of Rs. 10/- each into Equity Shares of Rs. 2/- each, subject to approval of the shareholders & to alter the Object Clause of the MoA of the Company. |
Jul 29, 2011 | Quarterly Results | - |
May 25, 2011 | Audited Results & Dividend | - |
Feb 07, 2011 | Quarterly Results | - |
Oct 21, 2010 | Quarterly Results | - |
Oct 11, 2010 | To consider the Merger | - |
Jul 29, 2010 | Quarterly Results | - |
May 05, 2010 | Audited Results & Dividend | - |
Jan 21, 2010 | Quarterly Results | - |
Dec 01, 2009 | Rights Issue | The Board have approved the Company's plan to raise funds by way of issue of Equity Shares on a Rights basis to the existing Shareholders of the Company for an aggregate amount of around Rs. 5.5 Crs. |
Oct 23, 2009 | Quarterly Results & ESOP | The Board has allotted 6700 Equity Shares of Rs. 10/- each to Employees / Directors who have exercised their options to apply for Equity Shares at an exercise price of Rs. 50/- per share. |
Jul 29, 2009 | Quarterly Results | - |
Jun 01, 2009 | Audited Results & Dividend | - |
Jan 16, 2009 | Quarterly Results | - |
Jan 08, 2009 | Others | To appoint Mr. Bhargav Patel as an Additional Director of the co.. to alter in Clause III (C) Other Objects Clause of the MoA of the Co. & to approve the commencement of new business. |
Oct 16, 2008 | Quarterly Results | - |
Jul 29, 2008 | Quarterly Results & Others | To approve the proposal for setting up a Joint Venture Company between the Company and Pagoda Advisors Pvt Ltd & their associates. |
Jun 26, 2008 | Audited Results, Dividend & Others | 1. Consideration of Audited Financial Results for the year ended March 31, 2008. 2. Recommendation of Dividend. |
Jan 21, 2008 | Quarterly Results | - |
Oct 25, 2007 | Quarterly Results | - |
Jul 25, 2007 | Quarterly Results | - |
Jun 11, 2007 | Audited Results | - |
Ex-Date | Bonus Ratio | Record Date |
---|
CAMLIN FINE SCIENCES LTD. - 532834 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI (DP) RegulationsCAMLIN FINE SCIENCES LTD. - 532834 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication relating to 31st Annual General Meeting to be held on Wednesday, July 31, 2024 at 11.00 a.m. (IST) via VC/OAVM.CAMLIN FINE SCIENCES LTD. - 532834 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation - Loss of share certificateCAMLIN FINE SCIENCES LTD. - 532834 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
ESOP - AllotmentCAMLIN FINE SCIENCES LTD. - 532834 - Closure of Trading Window
Intimation for Closure of Trading Window.CAMLIN FINE SCIENCES LTD. - 532834 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation - Loss of Share CertificateCamlin Fine Sciences Shares Jump 10% After Belgian Acquisition
The subsidiary acquired a 100% stake in Vitafor for a consideration of 1, according to an exchange filing.CAMLIN FINE SCIENCES LTD. - 532834 - Announcement under Regulation 30 (LODR)-Acquisition
Our wholly owned subsidiary viz. Dresen Quimica SAPI De CV, Mexico, has entered into an Share Purchase Agreement (SPA) to acquire 100% stake in Vitafor Invest NV, Belgium and its underlying subsidiaries/associates.CAMLIN FINE SCIENCES LTD. - 532834 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance ReportCAMLIN FINE SCIENCES LTD. - 532834 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Investor callThe latest market price of Camlin Fine Sciences Ltd. on NSE was Rs. 106.98 as of today.
The opening share price of Camlin Fine Sciences Ltd. was Rs. 105.20 as of today.
The 52-week high share price of Camlin Fine Sciences Ltd. was Rs. 186.40.
The 52 week low share price of Camlin Fine Sciences Ltd. was Rs. 80.00.
The PE ratio of Camlin Fine Sciences Ltd. is 0.10. Please refer to the Fundamentals section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest dividend declared by Camlin Fine Sciences Ltd. was on 2016-07-28 for Rs. 0.45 per share. According to today’s share price, the dividend yield of Camlin Fine Sciences Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.
The latest split issue declared by Camlin Fine Sciences Ltd. was as of 2012-02-15. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Camlin Fine Sciences Ltd..